Hikma Pharmaceuticals
Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.
HIKMA PHARMACEUTICALS annual revenue was 2,517 million GBP and annual net income was 188 million GBP generated for period year ending Dec-2022.
HIKMA PHARMACEUTICALS annual revenue was 2,553 million GBP and annual net loss was 421 million GBP generated for period year ending Dec-2021.
As on 2022, HIKMA PHARMACEUTICALS had 8800 employees.